Deutsche Bank AG Buys 27,688 Shares of Ventas, Inc. $VTR

Deutsche Bank AG grew its stake in Ventas, Inc. (NYSE:VTRFree Report) by 0.7% in the 4th quarter, Holdings Channel reports. The firm owned 3,904,293 shares of the real estate investment trust’s stock after purchasing an additional 27,688 shares during the period. Deutsche Bank AG’s holdings in Ventas were worth $302,114,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in VTR. NewEdge Advisors LLC raised its holdings in Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC boosted its position in shares of Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after purchasing an additional 536 shares in the last quarter. Woodline Partners LP boosted its position in shares of Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares in the last quarter. Focus Partners Wealth boosted its position in shares of Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares in the last quarter. Finally, Gamco Investors INC. ET AL bought a new stake in shares of Ventas during the second quarter valued at approximately $805,000. 94.18% of the stock is currently owned by institutional investors.

Ventas Stock Performance

Shares of VTR stock opened at $84.65 on Thursday. Ventas, Inc. has a one year low of $61.76 and a one year high of $91.06. The company’s 50-day moving average is $85.06 and its 200 day moving average is $82.44. The company has a market capitalization of $41.15 billion, a price-to-earnings ratio of 153.91, a price-to-earnings-growth ratio of 1.77 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25.

Ventas (NYSE:VTRGet Free Report) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period last year, the company posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts expect that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.5%. Ventas’s dividend payout ratio is currently 378.18%.

Insider Activity

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.53% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “buy (b-)” rating on shares of Ventas in a research report on Friday, March 27th. Royal Bank Of Canada lifted their price target on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Mizuho set a $98.00 price target on Ventas in a research report on Friday, May 22nd. Evercore restated an “outperform” rating and set a $95.00 price target on shares of Ventas in a research report on Wednesday, April 29th. Finally, KeyCorp lifted their price target on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.19.

Read Our Latest Stock Report on Ventas

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.